Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Induced Pluripotent Stem Cells Production Market, by Region, 2019-2027 (USD Billion)
1.2.2. Induced Pluripotent Stem Cells Production Market, by Derived Cell Type, 2019-2027 (USD Billion)
1.2.3. Induced Pluripotent Stem Cells Production Market, by Application, 2019-2027 (USD Billion)
1.2.4. Induced Pluripotent Stem Cells Production Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Induced Pluripotent Stem Cells Production Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Induced Pluripotent Stem Cells Production Market Dynamics
3.1. Induced Pluripotent Stem Cells Production Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High usage of iPSCs in treating injuries
3.1.1.2. Rising demand for reproducible large-scale stem cell
3.1.2. Market Challenges
3.1.2.1. High cost of reprograming of cells
3.1.3. Market Opportunities
3.1.3.1. Favourable government initiatives
Chapter 4. Global Induced Pluripotent Stem Cells Production Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Induced Pluripotent Stem Cells Production Market, by Derived Cell Type
5.1. Market Snapshot
5.2. Global Induced Pluripotent Stem Cells Production Market by Derived Cell Type, Performance - Potential Analysis
5.3. Global Induced Pluripotent Stem Cells Production Market Estimates & Forecasts by Derived Cell Type 2018-2027 (USD Billion)
5.4. Induced Pluripotent Stem Cells Production Market, Sub Segment Analysis
5.4.1. Hepatocytes
5.4.2. Fibroblasts
5.4.3. Keratinocytes
5.4.4. Amniotic Cells
5.4.5. Others
Chapter 6. Global Induced Pluripotent Stem Cells Production Market, by Application
6.1. Market Snapshot
6.2. Global Induced Pluripotent Stem Cells Production Market by Application, Performance - Potential Analysis
6.3. Global Induced Pluripotent Stem Cells Production Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Induced Pluripotent Stem Cells Production Market, Sub Segment Analysis
6.4.1. Academic Research
6.4.2. Drug Development And Discovery
6.4.3. Toxicity Screening
6.4.4. Regenerative Medicine
Chapter 7. Global Induced Pluripotent Stem Cells Production Market, by End-User
7.1. Market Snapshot

7.2. Global Induced Pluripotent Stem Cells Production Market by End-User, Performance - Potential Analysis

7.3. Global Induced Pluripotent Stem Cells Production Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)

7.4. Induced Pluripotent Stem Cells Production Market, Sub Segment Analysis

7.4.1. Hospitals

7.4.2. Research Laboratories

Chapter 8. Global Induced Pluripotent Stem Cells Production Market, Regional Analysis
8.1. Induced Pluripotent Stem Cells Production Market, Regional Market Snapshot
8.2. North America Induced Pluripotent Stem Cells Production Market
8.2.1. U.S. Induced Pluripotent Stem Cells Production Market
8.2.1.1. Derived Cell Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Application breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Induced Pluripotent Stem Cells Production Market
8.3. Europe Induced Pluripotent Stem Cells Production Market Snapshot
8.3.1. U.K. Induced Pluripotent Stem Cells Production Market
8.3.2. Germany Induced Pluripotent Stem Cells Production Market
8.3.3. France Induced Pluripotent Stem Cells Production Market
8.3.4. Spain Induced Pluripotent Stem Cells Production Market
8.3.5. Italy Induced Pluripotent Stem Cells Production Market
8.3.6. Rest of Europe Induced Pluripotent Stem Cells Production Market
8.4. Asia-Pacific Induced Pluripotent Stem Cells Production Market Snapshot
8.4.1. China Induced Pluripotent Stem Cells Production Market
8.4.2. India Induced Pluripotent Stem Cells Production Market
8.4.3. Japan Induced Pluripotent Stem Cells Production Market
8.4.4. Australia Induced Pluripotent Stem Cells Production Market
8.4.5. South Korea Induced Pluripotent Stem Cells Production Market
8.4.6. Rest of Asia Pacific Induced Pluripotent Stem Cells Production Market
8.5. Latin America Induced Pluripotent Stem Cells Production Market Snapshot
8.5.1. Brazil Induced Pluripotent Stem Cells Production Market
8.5.2. Mexico Induced Pluripotent Stem Cells Production Market
8.6. Rest of The World Induced Pluripotent Stem Cells Production Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Lonza
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Axol Bioscience Ltd.
9.2.3. Evotec
9.2.4. Hitachi Ltd.
9.2.5. Merck KGaA
9.2.6. REPROCELL Inc.
9.2.7. Fate Therapeutics
9.2.8. Thermo Fisher Scientific, Inc.
9.2.9. StemCellFactory III
9.2.10. Applied StemCell Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption